---

---

entities : Sanofi    crawled time : 18:00   

save search

---

Sanofi: Information concerning the total number of voting rights and shares - March 2024
Published: 2024-04-12 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.385 2.19% 3M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
total

---

Consumer Healthcare Market, 33% of Growth to Originate from North America, Technavio
Published: 2024-04-10 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.64% | O: -100.0% H: NaN% C: Infinity%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -4.43% | O: -0.64% H: 0.0% C: 0.0%
ABT | News | $107.4 2.02% 6.4M |

Health Technology

| -4.29% | O: 0.43% H: 0.3% C: -0.18%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -3.95% | O: 0.05% H: 0.0% C: 0.0%
growth

---

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 1.57% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -5.76% | O: -0.25% H: 1.1% C: -0.17%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -2.83% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -5.88% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -16.04% | O: 0.38% H: 0.0% C: -7.27%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -1.64% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -3.02% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 1.21% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

---

Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| Email alert Add to watchlist
GILD | News | $66.77 0.92% 0.91% 11M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
GMAB | $28.72 1.38% 1.36% 360K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.385 2.19% 3M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
GNMSF | $290.38 3.83% 220 |

Health Technology

| Email alert Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| Email alert Add to watchlist
research global leukemia therapeutics market

---

Global Urological Disorders Drugs Market Competitive Analysis, with Profiles of Leading Companies AbbVie, AstraZeneca, Merck & Co., Novartis, Pfizer and more
Published: 2024-03-26 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.86% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -7.5% | O: 1.06% H: 0.0% C: 0.0%
companies merck disorders global market

---

Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
Published: 2024-03-14 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.82% | O: 0.23% H: 0.0% C: 0.0%
italy

---

Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M |

Health Technology

| -7.83% | O: -0.64% H: 0.94% C: -0.56%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.2% | O: 0.66% H: 0.0% C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -0.55% | O: 0.27% H: 0.5% C: 0.11%
ABT | News | $107.4 2.02% 6.4M |

Health Technology

| -11.47% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.85% | O: -0.04% H: 0.0% C: 0.0%
report distribution year global market

---

Global Dyslipidemia Drugs Market Set to Reach $30.98 Billion by 2034 with Statins Dominating and PCSK9 Inhibitors Showing Rapid Growth
Published: 2024-03-08 (Crawled : 18:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 4.68% | O: 3.21% H: 0.0% C: -1.71%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.42% | O: -0.68% H: 0.0% C: 0.0%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.38% | O: -0.08% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 3.13% | O: -0.03% H: 0.62% C: 0.5%
rapid reach global set growth market

---

FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
PRGO | $30.625 2.29% 640K |

Health Technology

| 1.18% | O: 0.98% H: 3.17% C: 0.9%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.42% | O: -0.68% H: 0.0% C: 0.0%
ABT | News | $107.4 2.02% 6.4M |

Health Technology

| -11.4% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.38% | O: -0.08% H: 0.0% C: 0.0%
fda brukinsa approval

---

Global Hemophilia Market Analysis Report 2023-2028: Increased Focus on Prophylactic Treatment and Shifting Focus to Extended Half Life Therapies
Published: 2024-03-07 (Crawled : 18:00) - prnewswire.com
SNY | News | $46.385 2.19% 3M |

Health Technology

| -3.86% | O: 1.62% H: 0.0% C: 0.0%
report life treatment global market

---

Biopharma Layoff Tracker 2024: Sumitomo, Meissa, Pfizer and More Cut Staff
Published: 2024-03-06 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
RLYB | $1.75 4.79% 4.57% 310K |

| -7.82% | O: -0.27% H: 4.32% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.77% | O: -0.67% H: 0.0% C: 0.0%
VXRT | $0.7652 -9.15% -10.08% 1.9M |

Health Technology

| -28.1% | O: -0.83% H: 3.33% C: 0.0%
TXMD | $1.86 -1.59% -1.61% 10K |

Health Technology

| -29.74% | O: 1.86% H: 0.36% C: -10.58%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -4.29% | O: -0.45% H: 0.0% C: 0.0%
PTCT | $25.14 1.82% 650K |

Health Technology

| -19.62% | O: 1.82% H: 0.09% C: -3.11%
NKTR | $1.265 -4.17% -4.35% 4.7M |

Health Technology

| 52.7% | O: -0.46% H: 5.68% C: 3.4%
MOR | $17.96 -0.5% -0.5% 180K |

Health Technology

| 2.04% | O: 0.28% H: 0.93% C: 0.34%
GLPG | $29.08 0.59% 82K |

Health Technology

| -15.33% | O: 0.26% H: 0.06% C: -0.46%
AMRN | $0.88 0.94% 0.93% 1M |

Health Technology

| -1.29% | O: 0.95% H: 3.02% C: -0.08%
GOOGL | News S | $154.08 -1.24% -1.25% 31M |

Technology Services

| 17.06% | O: 0.34% H: 0.35% C: -1.29%
GOOG | News S | $155.7 -1.12% -1.13% 20M |

Technology Services

| 17.29% | O: 0.34% H: 0.37% C: -1.25%
OCX J | $2.495 -2.54% -2.61% 50K |

Health Technology

| -14.24% | O: 0.0% H: 1.33% C: -0.33%
biopharma

---

Valo Health Completes Enrollment of OPL-0401 Phase 2 Study for the Treatment of Diabetic Retinopathy
Published: 2024-03-04 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.9% | O: -0.9% H: 0.0% C: 0.0%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -3.95% | O: -0.8% H: 0.0% C: 0.0%
opl-0401 health treatment study diabetic

---

Full-year 2023 results
Published: 2024-02-28 (Crawled : 18:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.89% | O: -1.6% H: 0.0% C: 0.0%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.28% | O: -0.11% H: 0.0% C: 0.0%
results

---

C-Suite Shuffle: ReNAgade, Adaptimmune, Vittoria and More
Published: 2024-02-28 (Crawled : 18:00) - biospace.com/
ABT | News | $107.4 2.02% 6.4M |

Health Technology

| -9.96% | O: 1.12% H: 0.52% C: 0.47%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.87% | O: -0.63% H: 0.0% C: 0.0%

---

Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Published: 2024-02-23 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.02% | O: 0.97% H: 0.0% C: 0.0%
report financial

---

United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published: 2024-02-22 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.97% | O: 0.37% H: 0.58% C: 0.58%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -9.46% | O: 0.89% H: 0.4% C: 0.17%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -2.45% | O: 0.57% H: 0.47% C: -0.58%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -5.9% | O: 0.14% H: 1.01% C: 0.51%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -6.56% | O: 0.29% H: 0.93% C: 0.47%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.02% | O: 0.97% H: 0.0% C: 0.0%
GILD | News | $66.77 0.92% 0.91% 11M |

Health Technology

| -8.08% | O: 0.65% H: 1.35% C: 0.41%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -7.1% | O: 0.47% H: 2.0% C: 0.93%
pharmaceuticals market

---

Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
Published: 2024-02-22 (Crawled : 18:00) - globenewswire.com
ALSMY | $1.57 -1.78% 410K |

Manufacturing

| 17.74% | O: 0.0% H: 0.56% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -6.07% | O: 0.45% H: 0.24% C: -0.31%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -5.02% | O: 0.97% H: 0.0% C: 0.0%

---

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| -5.84% | O: -0.08% H: 3.47% C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 0.15% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -9.47% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K |

Health Technology

| 8.5% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -15.79% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

---

Danny Robinson Named CEO of The Martin Agency
Published: 2024-01-30 (Crawled : 18:00) - globenewswire.com
IPG | $30.745 1.17% 2.1M |

Commercial Services

| -9.37% | O: -0.3% H: 0.81% C: -0.09%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -9.36% | O: 0.12% H: 0.0% C: 0.0%
ceo

---

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -15.47% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -19.48% | O: -3.53% H: 3.49% C: 3.4%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -13.77% | O: -0.59% H: 0.49% C: 0.41%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 1.38% | O: 0.26% H: 0.13% C: -0.18%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 0.76% | O: 0.19% H: 0.46% C: 0.43%
SNY | News | $46.385 2.19% 3M |

Health Technology

| -9.36% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

---

Gainers vs Losers

65%

35%

Top 10 Gainers

AGBA | News | $1.305 226.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

INSG | $3.03 25.21% 330K |

Electronic Technology

KNW 4 | $0.59 -0.71% 18.64% 27K |

Manufacturing

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---